Fully set dinner table
Biotech

After 3 acquisitions, Gilead shifts focus to expanded pipeline

After entering 2026 hungry for deals, Gilead Sciences has wasted no time eating its fill.
Darren Incorvaia Apr 8, 2026 4:00am
Vivtex Cambridge HQ

After $2.1B Novo deal, Vivtex is just getting started

Apr 8, 2026 8:00am
Sonoran sidewinder rattlesnake

OrbiMed’s Sidewinder slithers ahead with $137M series B for ADCs

Apr 8, 2026 7:00am
research deal two people shaking hands in lab

Astellas, Dyno unearth $15M muscle disorder capsid

Apr 8, 2026 8:00am
CRO lab

Akari locks arms with WuXi XDC to develop and manufacture ADC

Apr 8, 2026 11:30am
fundraise tracker 2026

Fierce Biotech Fundraising Tracker '26: Life Bio, Sidewinder & more

Apr 8, 2026 9:00am
More News

Jeito's $1.2B ‘largest ever’ for independent Euro biopharma fund

Apr 8, 2026 5:01am
Fierce Pharma

FDA's Makary shares policy requests with Congress

Apr 7, 2026 11:04am

CRO Fortrea launches AI solution to improve trial efficiency

Apr 7, 2026 11:01am

Lilly pays AC Immune $12.5M to expand Alzheimer’s collab

Apr 7, 2026 9:30am